Refine
Has Fulltext
- yes (7)
Is part of the Bibliography
- yes (7)
Document Type
- Journal article (7)
Language
- English (7) (remove)
Keywords
- ELISPOT (6)
- B cells (4)
- MS (3)
- predictive value (2)
- relapse (2)
- ANOVA (1)
- CD4 (1)
- CD4 T cells (1)
- CD8 (1)
- CMV (1)
- EBV (1)
- Enzyme-Linked Immunospot assay (ELISPOT) (1)
- HCMV infection (1)
- IFN-γ (1)
- IL-17 (1)
- IL-2 (1)
- IL-4 (1)
- IL-5 (1)
- Normal Distribution (1)
- T cell assay (1)
- T cells (1)
- T-cells (1)
- acceptance (1)
- activation (1)
- apoptosis (1)
- chronic viral infection (1)
- cytokine secretion kinetics (1)
- cytokines (1)
- cytomegalovirus (1)
- elispot (1)
- exhaustion (1)
- gating (1)
- hcv infection (1)
- human cytomegalovirus (HCMV) (1)
- memory cells (1)
- normal distribution (1)
- signature (1)
- software (1)
- spot size (1)
- statistics (1)
- t-Test (1)
- viability (1)
There is a largely divergent body of literature regarding the relationship between Epstein-Barr virus (EBV) infection and brain inflammation in multiple sclerosis (MS). Here, we tested MS patients during relapse (n = 11) and in remission (n = 19) in addition to n = 22 healthy controls to study the correlation between the EBV- and brain-specific B cell response in the blood by enzyme-linked immunospot (ELISPOT) and enzyme-linked immunosorbent assay (ELISA). Cytomegalovirus (CMV) was used as a control antigen tested in n = 16 MS patients during relapse and in n = 35 patients in remission. Over the course of the study, n = 16 patients were untreated, while n = 33 patients received immunomodulatory therapy. The data show that there was a moderate correlation between the frequencies of EBV- and brain-reactive B cells in MS patients in remission. In addition we could detect a correlation between the B cell response to EBV and disease activity. There was no evidence of an EBV reactivation. Interestingly, there was also a correlation between the frequencies of CMV- and brain-specific B cells in MS patients experiencing an acute relapse and an elevated B cell response to CMV was associated with higher disease activity. The trend remained when excluding seronegative subjects but was non-significant. These data underline that viral infections might impact the immunopathology of MS, but the exact link between the two entities remains subject of controversy.